drugset / Trial / NCT05661591

Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects

NCT05661591

Phase 1 Completed 18 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study is being conduct to evaluate fluconazole effect of on SHR2554 in condition of single-canter, open-label, single-dose in healthy subjects. To explore the SHR2554 pharmacokinetics change under use of fluconazole and insure the safety with SHR2554 combined with fluconazole.

Timeline

Start
2023-02-28
Primary completion
2023-03-31
Completion
2023-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluconazole Small molecule
Subject SHR2554 Small molecule

Indications